<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The effect of systemic intraperitoneal administration of different doses of the PBFEO (100, 200, and 400 mg/kg) on the behavioral responses during the first (phase I) and the second phases (phase II) of the formalin test were calculated. In formalin test, morphine revealed antinociceptive effects in both phases I and phase II (
 <xref ref-type="fig" rid="F2" class="xref">Figure 2</xref>) but PBFEO did not produce any antinociception effect compared with the control group.
</p>
